Company Arcturus Therapeutics Holdings Inc.
Equities
ARCT
US03969T1097
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
24.35 USD | -0.41% | -11.29% | -22.77% |
Business Summary
Number of employees: 180
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Nucleic Acid-focused Technology
100.0
%
| 206 | 100.0 % | 167 | 100.0 % | -19.03% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 206 | 100.0 % | 167 | 100.0 % | -19.03% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Joseph Payne
CEO | Chief Executive Officer | 52 | 01/13/01 |
Andrew Sassine
DFI | Director of Finance/CFO | 59 | 01/19/01 |
Chief Operating Officer | 45 | 01/13/01 | |
Chief Tech/Sci/R&D Officer | 68 | 01/23/01 | |
Neda Safarzadeh
IRC | Investor Relations Contact | - | - |
Lance Kurata
LAW | General Counsel | 54 | 10/20/10 |
Kevin T. Skol
PRN | Corporate Officer/Principal | - | 01/02/01 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Edward Holmes
BRD | Director/Board Member | 83 | 01/19/01 |
James Barlow
BRD | Director/Board Member | 65 | 27/18/27 |
Peter Farrell
CHM | Chairman | 81 | 27/18/27 |
Andrew Sassine
DFI | Director of Finance/CFO | 59 | 01/19/01 |
Magda Marquet
BRD | Director/Board Member | 65 | 27/18/27 |
Jing Marantz
BRD | Director/Board Member | 58 | 07/21/07 |
Joseph Payne
CEO | Chief Executive Officer | 52 | 01/13/01 |
John Markels
BRD | Director/Board Member | 58 | 08/22/08 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 26,931,826 | 24,640,838 ( 91.49 %) | 0 | 91.49 % |
Company contact information
Arcturus Therapeutics Holdings, Inc.
10628 Science Center Drive Suite 250
92121, San Diego
+
http://www.arcturusrx.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-22.77% | 66Cr | |
+19.41% | 4.55TCr | |
+38.65% | 3.81TCr | |
-8.62% | 3.85TCr | |
+26.95% | 3.07TCr | |
-13.50% | 2.6TCr | |
+10.74% | 2.59TCr | |
+44.87% | 1.41TCr | |
+34.36% | 1.27TCr | |
-7.14% | 1.13TCr |
- Stock Market
- Equities
- ARCT Stock
- Company Arcturus Therapeutics Holdings Inc.